Selective serotonin reuptake inhibitors affect structure, function and metabolism of skeletal muscle: A systematic review

被引:10
|
作者
Visco, Diego Bulcao [1 ]
Manhaes-de-Castro, Raul [2 ]
Chaves, Wenicios Ferreira [1 ]
Lacerda, Diego Cabral [1 ]
Pereira, Sabrina da Conceicao [3 ]
Ferraz-Pereira, Kelli Nogueira [4 ]
Toscano, Ana Elisa [5 ]
机构
[1] Univ Fed Pernambuco, Postgrad Program Nutr, Recife, PE, Brazil
[2] Univ Fed Pernambuco, Dept Nutr, Recife, PE, Brazil
[3] Univ Fed Pernambuco, Postgrad Program Phys Therapy, Recife, PE, Brazil
[4] Univ Fed Pernambuco, CAV, Dept Phys Educ & Sports Sci, Vitoria De Santo Antao, PE, Brazil
[5] Univ Fed Pernambuco, CAV, Dept Nursing, Rua Alto Reservatorio S-N, BR-55608680 Vitoria De Santo Antao, PE, Brazil
关键词
Serotonin uptake inhibitors; Serotonin; Skeletal muscle; Systematic review; CONGENITAL MYASTHENIC SYNDROME; CUTANEOUS SILENT PERIOD; FLUOXETINE TREATMENT; MYOTONIC-DYSTROPHY; GLUCOSE-METABOLISM; INSULIN-RESISTANCE; NEONATAL TREATMENT; DIABETES-MELLITUS; RAT; ANTIDEPRESSANTS;
D O I
10.1016/j.phrs.2018.09.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Selective Serotonin Reuptake Inhibitors (SSRIs) may have side effects, such as stiffness, tremors and altered tonic activity, as well as an increased risk of developing insulin resistance and diabetes mellitus. However, little is known about the structural, functional and metabolic changes of skeletal muscle after administration of SSRIs. The aim of this systematic review was to explore and discuss the effects of SSRIs on skeletal muscle properties described in human and rodent studies. A systematic search of PUBMED, SCOPUS, and WEB OF SCIENCE was performed. The inclusion criteria were intervention studies in humans and rodents that analysed the effects of SSRIs on skeletal muscle properties. The research found a total of six human studies, including two randomized controlled trials, one non-randomized controlled trial, one uncontrolled before-after study and two case reports, and six preclinical studies in rodents. Overall, the studies in humans and rodents showed altered electrical activity in skeletal muscle function, assessed through electromyography (EMG) and needle EMG in response to chronic treatment or local injection with SSRIs. In addition, rodent studies reported that SSRIs may exert effects on muscle weight, the number of myocytes and the cross-sectional area of skeletal muscle fibre. The results showed effects in energy metabolism associated with chronic SSRI use, reporting altered levels of glycogen synthase activity, acetyl-CoA carboxylase phosphorylation, citrate synthase activity, and protein kinase B Ser phosphorylation. Moreover, changes in insulin signalling and glucose uptake were documented. In this context, we concluded based on human and rodent studies that SSRIs affect electrical muscle activity, structural properties and energy metabolism in skeletal muscle tissue. However, these changes varied according to pre-existing metabolic and functional conditions in the rodents and humans.
引用
收藏
页码:194 / 204
页数:11
相关论文
共 50 条
  • [31] SELECTIVE SEROTONIN REUPTAKE INHIBITORS
    WALLEY, T
    BRITISH MEDICAL JOURNAL, 1992, 305 (6852): : 526 - 526
  • [32] SELECTIVE SEROTONIN REUPTAKE INHIBITORS
    EDWARDS, JG
    BRITISH MEDICAL JOURNAL, 1992, 304 (6843): : 1644 - 1646
  • [33] Cause or Effect? Selective Serotonin Reuptake Inhibitors and Falls in Older Adults: A Systematic Review
    Gebara, Marie Anne
    Lipsey, Kim L.
    Karp, Jordan F.
    Nash, Maureen C.
    Iaboni, Andrea
    Lenze, Eric J.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2015, 23 (10): : 1016 - 1028
  • [34] Selective Serotonin Reuptake Inhibitors for Stroke Recovery A Systematic Review and Meta-analysis
    Mead, Gillian E.
    Hsieh, Cheng-Fang
    Lee, Rebecca
    Kutlubaev, Mansur
    Claxton, Anne
    Hankey, Graeme J.
    Hackett, Maree
    STROKE, 2013, 44 (03) : 844 - +
  • [35] The Effect of Selective Serotonin Reuptake Inhibitors in Healthy Subjects Revisited: A Systematic Review of the Literature
    Knorr, Ulla
    Madsen, Jasmine Melissa
    Kessing, Lars Vedel
    EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2019, 27 (05) : 413 - 432
  • [36] SELECTIVE SEROTONIN REUPTAKE INHIBITORS FOR STROKE RECOVERY: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Mead, G.
    Legg, L.
    Hua, X.
    Wu, S.
    Hackett, M.
    Hsieh, C. -F.
    Barugh, A.
    Lundstrom, E.
    Lindgren, L.
    Rudberg, A. S.
    Kutlubaev, M.
    Tilney, R.
    Dennis, M.
    Hankey, G.
    INTERNATIONAL JOURNAL OF STROKE, 2021, 16 (3_SUPPL) : 15 - 15
  • [37] Selective Serotonin Reuptake Inhibitors and Symptoms of Depression in Patients on Chronic Hemodialysis: A Systematic Review
    Bossola, Maurizio
    Mariani, Ilaria
    Antocicco, Manuela
    Pepe, Gilda
    Petrosino, Anna
    Di Stasio, Enrico
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (11)
  • [38] The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials
    Azizi, Marzieh
    Khani, Soghra
    Kamali, Mahsa
    Elyasi, Forouzan
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2022, 47 (03) : 173 - 193
  • [39] Selective Serotonin Reuptake Inhibitors Affect Neurobehavioral Development in the Human Fetus
    Eduard J H Mulder
    Frédérique FT Ververs
    Roel de Heus
    Gerard H A Visser
    Neuropsychopharmacology, 2011, 36 : 1961 - 1971
  • [40] Selective Serotonin Reuptake Inhibitors Affect Neurobehavioral Development in the Human Fetus
    Mulder, Eduard J. H.
    Ververs, Frederique F. T.
    de Heus, Roel
    Visser, Gerard H. A.
    NEUROPSYCHOPHARMACOLOGY, 2011, 36 (10) : 1961 - 1971